Skip to main navigation
 
Manage Cookie Consent
 
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
 
View preferences
Privacy and Cookie Notice {title} {title}
Quoin Pharmaceuticals, Inc.
  • Home
  • About
    • Who We Are
    • Timeline/History
    • Leadership
    • Board
    • Partners
  • Pipeline
    • Pipeline
    • Indications
    • About Netherton Syndrome
    • Patients & Families
    • Resources
    • Clinical Trial FAQs
  • Investors
    • Company Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Corporate Governance
    • IR Resources
  • Contact


Events & Presentations

  • Company Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
    • CVR Holders
  • Financial Information
    • SEC Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Officers
    • Committee Composition
    • Board Diversity Matrix
  • IR Resources
    • Email Alerts
    • Contact IR
Past Events
First Quarter 2023 Financial Results and Corporate Update Conference Call
May 9, 2023 at 8:30 AM EDT
Listen to webcast
2022 Business and Financial Update Conference Call
Mar 9, 2023 at 8:30 AM EST
Listen to webcast
Quoin Pharmaceuticals Ltd., Third Quarter Financial Results and Business Update Conference Call
Nov 10, 2022 at 10:00 AM EST
Listen to webcast
Second Quarter Financial Results and Business Update Conference Call
Aug 18, 2022 at 8:30 AM EDT
Listen to webcast
Presentations
Corporate Overview 1.4 MB
Quoin Pharmaceuticals, Inc. Logo

Subscribe

Sign up for alerts to stay up to date on Quoin Pharmaceuticals.

News:

May 24, 2023

Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial

May 08, 2023

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results

2023 © Quoin Pharmaceuticals, Inc. Privacy Policy
  • Linkedin
  • Twitter